Proprio CEO and co-founder, Gabriel Jones, was recently featured in MedTech Insight, discussing Paradigm’s FDA clearance and what the approval means for the medical technology industry.
In the article, titled “Innovative Spine Surgery Platform Wins FDA Clearance,” Jones explores what makes Proprio’s technology so unique.
“As the operative scene is captured digitally and fuses with preoperative scans, the surgeon can see the combined data sets in high definition, from any perspective, for the first time,” Jones said. “Paradigm provides an unprecedented understanding of the entire operative scene including location, depth, color and texture.”
Learn more about our surgical technology at Proprio here.
Read the full article here.
.svg)
.svg)
